Warning

Information for general practitioners

Updated 2026

The aim of treatment is to suppress disease activity and preserve joint function in the Inflammatory Arthropathies and other Rheumatic Disorders.

An Uncommonly used Drug in Rheumatoid Arthritis when Standard DMARDs are contraindicated or Ineffective/Not Tolerated

Dosage

  • 100mg twice daily - avoid in eGFR<30 (Renal guidance)

 

Monitoring procedure

  • Base line assessment only -FBC, U&E and LFT inc albumin
  • Further blood monitoring is not required, though intermittent LFTs are advised

 

Duration of treatment and time to response

  • Minocycline may take from 2-3 months, up to 1 year to be effective

 

Interactions

  • as per BNF - tetracyclines

 

Side effects

Rare or very rare:

  • acute CKD
  • drug-induced SLE
  • pigmentation
  • neuropathy
  • tinnitus

 

Hospital contacts

Secretaries 01387 241776

Helpline 01387 241095 (answering machine) Rheumatology Nurse Specialists

Department of Rheumatology doctors via Switchboard 01387 246246/RMS Advice

Editorial Information

Last reviewed: 12/03/2026

Next review date: 12/03/2028

Author(s): Lucy Moran.